Disease Info Card

Anaplastic Oligodendroglioma

Information about Anaplastic Oligodendroglioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Anaplastic Oligodendroglioma

Most recent studies have shown that Anaplastic Oligodendroglioma shares some biological mechanisms with anaplastic-astrocytoma, anaplastic-oligoastrocytoma, astrocytoma, brain-neoplasms, cell-transformation-neoplastic, ependymoma, glioblastoma, glioblastoma-multiforme, glioma, malignant-glioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, meningioma, mixed-oligodendroglioma-astrocytoma, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nervousness, oligodendroglioma, tumor-progression.

Among the many pathways, these few ones have gauged particular interests from scientists studying Anaplastic Oligodendroglioma, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Differentiation, Cell Growth, Cell Migration, Cell Proliferation, Dedifferentiation, Dna Repair, Immune Response, Interphase, Localization, Methylation, Mismatch Repair, Mitosis, Neurogenesis, Oligodendrocyte Development, Oncogenesis, Pathogenesis, Reverse Transcription, Sensitization

Quite a number of genes have been found to play important roles in Anaplastic Oligodendroglioma, such as AOX1, APTX, CDK4, CDKN2A, EGFR, GFAP, IDH1, MGMT, MID1, OLIG2, PGR, POMT1, PTEN, RB1, TEAD1, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.